Concepedia

Zhenzhen Luo

ZL

Statistics

Publications

7

Citations

183

H-Index

7

Active since

2016

Affiliations

First Affiliated Hospital of Xi'an Jiaotong University(Current)

Xi'an Jiaotong University

Yangtze University

Zhenzhen Luo is an author at First Affiliated Hospital of Xi'an Jiaotong University specializing in oncology, molecular oncology, and cancer cell signaling.

ORCID

Publications per year

2016–2023

7

Publications

7

Propranolol selectively inhibits cervical cancer cell growth by suppressing the cGMP/PKG pathway

Liuyun Gong, Yutiantian Lei, Xinyue Tan et al. · Biomedicine & Pharmacotherapy · 2019 · 41 citations · Full text

, , +15

A Novel Acid-Stable Endo-Polygalacturonase from Penicillium oxalicum CZ1028: Purification, Characterization, and Application in the Beverage Industry

Cheng Zhong, Dong Chen, Bo Lü et al. · Journal of Microbiology and Biotechnology · 2016 · 37 citations

, , +13

SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway

Zhenzhen Luo, Jing Wang, Yue Zhu et al. · Neoplasia · 2021 · 33 citations · Full text

, , +17

SPOP regulates the DNA damage response and lung adenocarcinoma cell response to radiation.

Yiping Dong, Dan Zhang, Mengjiao Cai et al. · PubMed · 2019 · 25 citations · Full text

, , +17

Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway

Liuyun Gong, Hanmin Tang, Zhenzhen Luo et al. · Clinical and Translational Medicine · 2020 · 19 citations · Full text

, , +16

1–5 of 7